MET and neoplasm: Recent data have indicated that matriptase may have a role in the activation of hepatocyte growth factor (Lee et al, 2000) and it will be of interest to determine whether this is integral to its action in the prostate, where there is evidence for participation of increased HGF-Met signalling in tumour progression (You et al, 2003; Hall et al, 2004).